4/A//SEC Filing
REYNO LEONARD 4/A
Accession 0001662579-25-000057
CIK 0001662579other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 9:00 AM ET
Size
6.8 KB
Accession
0001662579-25-000057
Insider Transaction Report
Form 4/AAmended
REYNO LEONARD
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-07-10$1.99/sh−7,382$14,690→ 166,382 total - Exercise/Conversion
Common Stock
2025-07-10+15,325→ 173,764 total
Footnotes (2)
- [F1]This amendment to the Form 4 originally filed on July 14, 2025 is being filed voluntarily to report the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on July 12, 2023.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001528716
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 9:00 AM ET
- Size
- 6.8 KB